Organization · Accelerator
Pebble
Pebble Accelerator is a Hong Kong-based organization that invests in early-stage healthcare startups, focusing on biomedical innovation and unique biotechnologies. It aims to build Hong Kong into a global biomedical nexus by supporting companies in achieving key milestones.
Overview
What Pebble does
What Pebble is
Pebble Accelerator is a Hong Kong-based organization that invests in early-stage healthcare startups, focusing on biomedical innovation and unique biotechnologies. It aims to build Hong Kong into a global biomedical nexus by supporting companies in achieving key milestones.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 27, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find Pebble elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pebble as a funder
Investment thesis
Pebble Accelerator focuses on biomedical innovation and unique biotechnologies, aiming to establish Hong Kong as a global biomedical nexus by supporting startups in achieving their milestones.
Focus narrative
Pebble Accelerator invests in early-stage startups, typically providing initial investments of around $200,000. In addition to funding, Pebble offers consulting services to companies outside its investment scope, acting as a bridge to connect them with opportunities in Hong Kong and beyond.
Value beyond capital
Pebble Accelerator adds value to its portfolio companies by providing not only financial support but also strategic consulting services. The firm acts as a connector, facilitating access to key markets and partners in Hong Kong and China, which enhances the growth potential of its startups.
Terms and economics
- Typical check
- $200,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Regions
- Asia · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 13
Portfolio context
Notable portfolio companies include: Opharmic: Develops ultrasound technology for eye treatments, enabling needle-free delivery of drugs. UniBioscience JV: Collaborates on developing therapeutic antibodies targeting obesity and diabetes. Xandar Kardian: Focuses on remote health monitoring using FDA-cleared radar technology. Innovac: A clinical-stage biotech company developing personalized mRNA cancer vaccines. Valora: Works on biologics for oncology and autoimmune diseases, utilizing technology from a Nobel Laureate. Oncoustics: Aims to revolutionize medical diagnostics with AI and acoustic data for liver assessments. Endiatx: Develops a swallowable mini robot for remote gastrointestinal diagnosis. Spiral Tx: Focuses on drug delivery methods for hearing loss and ear diseases. Heranova: Targets women's health with innovative diagnostic and therapeutic solutions. Thrive Bioscience: Develops automated cell culturing hardware and AI for cell analysis. Pacegenix: Incubated project developing prodrugs for cardiovascular conditions. Pilatus: Works on a CD36 Blocking Antibody for solid tumors, with FDA Orphan Drug Designation. Memora: Develops bispecific antibody-drug conjugates for neurodegenerative diseases. KA Imaging: A developer of advanced imaging technologies.
Capability profile
Pebble as a program host
Program thesis
Pebble Accelerator aims to build Hong Kong into a global biomedical nexus by supporting startups in biomedical innovation and unique biotechnologies.
Focus narrative
Pebble Accelerator invests in startups with initial investments of approximately US$200,000. It provides consulting services for companies outside its investment scope, acting as an extension in Hong Kong to facilitate connections with China and other global partners.
Value and support
Pebble Accelerator offers initial investments, consulting services, and connections to global partners, particularly in China, to support the growth of its portfolio companies.
Terms and economics
- Indicative investment
- $200,000
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator · Pre-seed · Seed
- Regions
- Asia · Global
Alumni and track record
Alumni context
Notable portfolio companies include Opharmic, which develops ultrasound technology for eye treatments; UniBioscience JV, focusing on therapeutic antibodies for obesity and diabetes; and Xandar Kardian, which specializes in remote health monitoring using FDA-cleared radar technology.
Common questions
What to know about Pebble
Upseed classifies Pebble under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.